Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 15 de 15
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Anal Chem ; 91(4): 3156-3162, 2019 02 19.
Artigo em Inglês | MEDLINE | ID: mdl-30682238

RESUMO

LC-MS based analysis of protein biopharmaceuticals could benefit from improved data quality, which can subsequently lead to improved drug characterization with higher confidence and less ambiguity. In this study, we created a simple device to modify the desolvation gas on a Q-Exactive mass spectrometer and to demonstrate the utility in improving both peptide mapping analysis and intact mass analysis, the two most routinely and widely applied LC-MS techniques in protein biopharmaceutical characterization. By modifying the desolvation gas with acid vapor from propionic acid (PA) and isopropanol (IPA), the ion suppression effects from trifluoroacetic acid (TFA) in a typical peptide mapping method can be effectively mitigated, thus leading to improved MS sensitivity. By modifying the desolvation gas with base vapor from triethylamine (TEA), the charge reduction effect can be achieved and utilized to improve the spectral quality from intact mass analysis of protein biopharmaceuticals. The approach and device described in this work suggests a low-cost and practical solution to improve the LC-MS characterization of protein biopharmaceuticals, which has the potential to be widely implemented in biopharmaceutical analytical laboratories.


Assuntos
Anticorpos Monoclonais/análise , Produtos Biológicos/análise , Cromatografia Líquida de Alta Pressão , Gases/química , Humanos , Espectrometria de Massas em Tandem
2.
Inflammation ; 41(3): 996-1007, 2018 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-29541888

RESUMO

Nobiletin (NOB), a citrus polymethoxy flavonoid, has been reported to exhibit anti-inflammatory, anti-cancer, and anti-insulin resistance activities. Although the anti-inflammatory activity of NOB already reported, its involvement in lung protection has not been reported. Thus, this study aimed to investigate the anti-inflammatory response of NOB in lipopolysaccharide (LPS)-stimulated A549 cells and LPS-induced acute lung injury (ALI) in mice. The animals were pre-treated with NOB (5, 10, and 20 mg/kg) or DEX (5 mg/kg) at 12 and 1 h before intranasal instillation of LPS. The severity of pulmonary injury was evaluated 6 h after LPS administration. Results suggested that treatment with NOB dramatically attenuated lung histopathological changes, wet-to-dry (W/D) ratio, myeloperoxidase (MPO) activity, the numbers of inflammatory cells, and TNF-α, IL-6, and NO in BALF induced by LPS. Furthermore, NOB also significantly inhibited the expression of iNOS and the phosphorylation of NF-κBp65 and IκBα. In vitro, NOB inhibited NF-κB activation and TNF-α, IL-6 production in LPS-stimulated A549 cells. Taken together, these results indicated that NOB exhibited a protective effect on ALI, and the possible mechanism is involved in inhibiting NF-κB activation, subsequently inhibiting LPS-induced inflammatory response.


Assuntos
Lesão Pulmonar Aguda/tratamento farmacológico , Flavonas/farmacologia , Inflamação/tratamento farmacológico , NF-kappa B/antagonistas & inibidores , Células A549 , Animais , Antioxidantes/farmacologia , Flavonas/uso terapêutico , Humanos , Inflamação/induzido quimicamente , Interleucina-6/metabolismo , Lipopolissacarídeos , Camundongos , NF-kappa B/metabolismo , Substâncias Protetoras/farmacologia , Fator de Necrose Tumoral alfa/metabolismo
3.
Biomed Pharmacother ; 95: 1091-1102, 2017 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-28922728

RESUMO

Fraxin, a main active component isolated from Cortex Fraxini, possesses a variety of bioactivities. However, there is a research gap in studies related to the hepatoprotective activity of fraxin against carbon tetrachloride (CCl4)-induced liver damage has been rarely studied. Thus, the purpose of this study is to evaluate the protective effect of fraxin against CCl4-induced liver damage in mice as well as in HepG2 cells, in addition to further improve the underlying mechanisms of hepatoprotective effect for fraxin. In mice model, pretreatment with fraxin (10, 20 or 40mg/kg) along with CCl4 significantly alleviated liver damage as indicated by the decreased levels of liver index, liver marker enzymes, lipid peroxidation, inflammatory mediators, increased levels of the antioxidant enzymatic and non-enzymatic defense parameters, and improved hepatic histopathology changes. Further, the results of the in vitro study conducted in HepG2 cells indicated that the CCl4-induced changes were significantly ameliorated by pretreatment of fraxin. Moreover, immunohistochemistry staining and western blot assay demonstrated that pretreatment with fraxin can down-regulate CCl4-induced protein expression of MAPKs, NF-κB and COX-2. Overall, these studies indicate that fraxin exhibits hepatoprotective effect against CCl4-induced liver damage by reducing inflammation response, suppressing oxidative stress and lipid peroxidation and enhancing antioxidant activity. The underlying mechanisms of fraxin in CCl4-induced acute liver injury may be due to inhibition of MAPK and NF-κB activation. It is possible for fraxin to be used as a hepatoprotective agent.


Assuntos
Antioxidantes/metabolismo , Cumarínicos/farmacologia , Inflamação/patologia , Fígado/patologia , Sistema de Sinalização das MAP Quinases/efeitos dos fármacos , NF-kappa B/metabolismo , Substâncias Protetoras/farmacologia , Animais , Biomarcadores Tumorais/metabolismo , Tetracloreto de Carbono , Cumarínicos/química , Citocinas/metabolismo , Células Hep G2 , Humanos , Imuno-Histoquímica , Inflamação/sangue , Peroxidação de Lipídeos/efeitos dos fármacos , Fígado/efeitos dos fármacos , Masculino , Camundongos , Estresse Oxidativo/efeitos dos fármacos , Substâncias Protetoras/química
4.
Immunopharmacol Immunotoxicol ; 39(6): 354-363, 2017 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-28948855

RESUMO

CONTEXT: Gastric ulcer is a common gastrointestinal disorder with increasing incidence and prevalence attributed to loss of balance between aggressive and protective factors. Nobiletin (NOB), a major component of polymethoxyflavones in citrus fruits, has a broad spectrum of health beneficial properties including anti-inflammatory and anti-tumor activities. Although NOB was originally shown to possess anti-inflammatory activity, its effects on gastric ulcer were rarely explored previously. OBJECTIVE: The aim of the present study was to investigate the anti-ulcerogenic activity of NOB on ethanol-induced gastric ulcer in mice and to elucidate the underlying mechanisms. METHODS: Seventy-two male Kunming mice administered with absolute ethanol (0.2 ml/animal) were pretreated with NOB (5, 10 or 20 mg/kg), cimetidine (100 mg/kg), or vehicles by intragastric administration in different experimental groups for three days, and animals were euthanized 3 h after ethanol ingestion. Gross and microscopic lesions, immunological and biochemical parameters were taken into consideration. RESULTS: The results showed that ethanol induced gastric injury, increased malondialdehyde (MDA) levels, decreased glutathione (GSH) content, superoxide dismutase (SOD) activity, and prostaglandin E2 (PGE2) levels, increased pro-inflammatory cytokines tumor necrosis factor-alpha (TNF-α) and interleukin-6 (IL-6) levels and myeloperoxidase (MPO) activity, as well as the expression MAPK signaling pathway. Pretreatment with NOB significantly attenuated the gastric lesions as compared to the ethanol group. CONCLUSIONS: These findings suggest that the gastroprotective activity is attribute to the improvement of antioxidant activities, the stimulation of PGE2, and the reduction of pro-inflammatory cytokines through the MAPK pathway.


Assuntos
Antiulcerosos/farmacologia , Flavonas/farmacologia , Inflamação/tratamento farmacológico , Estresse Oxidativo/efeitos dos fármacos , Substâncias Protetoras/farmacologia , Úlcera Gástrica/tratamento farmacológico , Animais , Anti-Inflamatórios/farmacologia , Antioxidantes/metabolismo , Citocinas/metabolismo , Dinoprostona/metabolismo , Etanol/farmacologia , Mucosa Gástrica/efeitos dos fármacos , Mucosa Gástrica/metabolismo , Glutationa/metabolismo , Inflamação/metabolismo , Interleucina-6/metabolismo , Masculino , Malondialdeído/metabolismo , Camundongos , Peroxidase/metabolismo , Úlcera Gástrica/induzido quimicamente , Úlcera Gástrica/metabolismo , Superóxido Dismutase/metabolismo , Fator de Necrose Tumoral alfa/metabolismo
5.
Phytother Res ; 31(10): 1557-1563, 2017 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-28840617

RESUMO

The yam (Dioscorea opposita Thunb) is a well-known edible food and widely used as the traditional Chinese medicine. The present investigation was designed to evaluate the immunomodulatory activity of glycoprotein (DOT) from yam and explore its possible molecular mechanisms. Results showed that the DOT could improve the cell immunity, humoral immunity and phagocytic system function of the normal mice. The DOT could also increase the production of TNF-α, interleukin-6 and nitric oxide and enhance the pinocytosis function of macrophages. Furthermore, the DOT increased phosphor-p38, JNK, ERK1/2 and nuclear factor kappa B (NF-κB) p65 protein expression in peritoneal macrophages. Taken together, our data suggest that DOT could be used as a potential immunostimulant and exert its immunomodulatory activity via mitogen-activated protein kinases and NF-κB signal pathways. Copyright © 2017 John Wiley & Sons, Ltd.


Assuntos
Dioscorea/química , Glicoproteínas/farmacologia , Imunomodulação/efeitos dos fármacos , Proteínas de Plantas/farmacologia , Animais , Feminino , Imunidade Celular , Imunidade Humoral , Interleucina-6/metabolismo , Macrófagos/efeitos dos fármacos , Macrófagos/metabolismo , Camundongos , Proteínas Quinases Ativadas por Mitógeno/metabolismo , Óxido Nítrico/metabolismo , Fosforilação , Transdução de Sinais , Fator de Transcrição RelA/metabolismo , Fator de Necrose Tumoral alfa/metabolismo
6.
Inflammation ; 40(4): 1111-1122, 2017 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-28365871

RESUMO

Acute lung injury (ALI) is characterized by widespread inflammation in the lungs and alveolar-capillary destruction, causing high morbidity and mortality. Cavidine, isolated from Corydalis impatiens, have been exhibited to have potent anti-inflammatory effects in previous studies. The purpose of this study was to evaluate the protective effect of cavidine on lipopolysaccharide (LPS)-induced ALI and to enunciate the underlying in vivo and in vitro mechanisms. Mice were intraperitoneally administrated with cavidine (1, 3, or 10 mg/kg) at 1 and 12 h, prior to the induction of ALI by intranasal administration of LPS (30 mg/kg). Blood samples, lung tissues, and bronchoalveolar lavage fluid (BALF) were harvested after LPS challenge. Furthermore, we used LPS-induced lung epithelial cells A549 to examine the mechanism of cavidine to lung injury. The results showed that pretreatment with cavidine significantly decreased lung wet-to-dry weight (W/D) ratio, reduced pro-inflammatory cytokine levels including TNF-α and IL-6 in BALF and serum from LPS-stimulated mice, and attenuated lung histopathological changes. In addition, western blot results showed that cavidine inhibited the phosphorylation of nuclear factor-kappaB (NF-κB) p65 and IκBα induced by LPS. In conclusion, our results demonstrate that cavidine protects against LPS-induced acute lung injury in mice via inhibiting of pro-inflammatory cytokine TNF-α and IL-6 production and NF-κB signaling pathway activation. Taken together, cavidine may be useful for the prevention and treatment of pulmonary inflammatory diseases, such as ALI.


Assuntos
Lesão Pulmonar Aguda/tratamento farmacológico , Alcaloides de Berberina/uso terapêutico , NF-kappa B/metabolismo , Transdução de Sinais/efeitos dos fármacos , Células A549 , Lesão Pulmonar Aguda/induzido quimicamente , Lesão Pulmonar Aguda/patologia , Animais , Alcaloides de Berberina/farmacologia , Líquido da Lavagem Broncoalveolar/química , Humanos , Inflamação/prevenção & controle , Mediadores da Inflamação/análise , Mediadores da Inflamação/sangue , Interleucina-6/sangue , Lipopolissacarídeos , Camundongos , Fosforilação/efeitos dos fármacos , Fator de Necrose Tumoral alfa/sangue
7.
Exp Cell Res ; 353(1): 26-34, 2017 04 01.
Artigo em Inglês | MEDLINE | ID: mdl-28274716

RESUMO

Pathogenesis of atherosclerosis is characterized by the proliferation and migration of vascular smooth muscle cells (VSMCs) and inflammatory lesions. The aim of this study is to elucidate the effect of atractylenolide I (AO-I) on smooth muscle cell inflammation, proliferation and migration induced by oxidized modified low density lipoprotein (Ox-LDL). Here, We found that atractylenolide I inhibited Ox-LDL-induced VSMCs proliferation and migration in a dose-dependent manner, and decreased the production of inflammatory cytokines and the expression of monocyte chemoattractant protein-1 (MCP-1) in VSMCs. The study also identified that AO-I prominently inhibited p38-MAPK and NF-κB activation. More importantly, the specific heme oxygenase-1 (HO-1) inhibitor zinc protoporphyrin (ZnPP) IX partially abolished the beneficial effects of atractylenolide I on Ox-LDL-induced VSMCs. Furthermore, atractylenolide I blocked the foam cell formation in macrophages induced by Ox-LDL. In summary, inhibitory roles of AO-I in VSMCs proliferation and migration, lipid peroxidation and subsequent inflammatory responses might contribute to the anti-atherosclerotic property of AO-I.


Assuntos
Heme Oxigenase-1/genética , Lactonas/farmacologia , Lipoproteínas LDL/fisiologia , Miócitos de Músculo Liso/fisiologia , Sesquiterpenos/farmacologia , Animais , Aterosclerose/tratamento farmacológico , Aterosclerose/imunologia , Aterosclerose/patologia , Movimento Celular/efeitos dos fármacos , Proliferação de Células/efeitos dos fármacos , Células Cultivadas , Avaliação Pré-Clínica de Medicamentos , Feminino , Células Espumosas/efeitos dos fármacos , Células Espumosas/fisiologia , Heme Oxigenase-1/metabolismo , Masculino , Camundongos , Músculo Liso Vascular/citologia , Miócitos de Músculo Liso/efeitos dos fármacos , Ratos Sprague-Dawley
8.
Fundam Clin Pharmacol ; 31(2): 174-184, 2017 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-27873354

RESUMO

The gastroprotective effect of esculin was investigated in a mouse model of ethanol-induced gastric lesion. Administration of esculin at doses of 5, 10, and 20 mg/kg body weight prior to ethanol ingestion led to significant gastroprotection compared with untreated mice. Gastric mucosal lesions were evaluated by macroscopic and histopathological alterations, lesion index, and myeloperoxidase (MPO) activity. Pretreatment with esculin significantly reduced macroscopic and histopathological damage, gastric lesion index, and MPO activity in a dose-dependent manner. Moreover, esculin significantly reduced nitric oxide (NO) production, inducible NO synthase (iNOS) levels, and nuclear factor-kappa B (NF-κB) p65 protein expression in gastric tissues after ethanol challenge. Analysis of inflammatory cytokines indicated that esculin pretreatment markedly suppressed the increased expression of tumor necrosis factor-alpha (TNF-α) and interleukin-6 (IL-6) in ethanol-treated mice. The results demonstrate a protective effect of esculin against gastric injury and suggest that the underlying mechanism might be associated with inhibition of NF-κB activation, which subsequently reduces expression of iNOS, TNF-α, and IL-6.


Assuntos
Esculina/farmacologia , Etanol/toxicidade , Mucosa Gástrica/efeitos dos fármacos , Úlcera Gástrica/prevenção & controle , Animais , Citocinas/metabolismo , Modelos Animais de Doenças , Relação Dose-Resposta a Droga , Esculina/administração & dosagem , Mucosa Gástrica/patologia , Interleucina-6/metabolismo , Masculino , Camundongos , Óxido Nítrico/metabolismo , Peroxidase/metabolismo , Úlcera Gástrica/induzido quimicamente , Fator de Necrose Tumoral alfa/metabolismo
9.
Eur J Pharmacol ; 791: 726-734, 2016 Nov 15.
Artigo em Inglês | MEDLINE | ID: mdl-27746168

RESUMO

Esculin, a coumarin compound derived from the traditional Chinese herbs such as Cortex Fraxini, has long been used for treating inflammatory and vascular diseases. In present study, we analyzed the role of esculin against macrophages and endotoxin shock induced by lipopolysaccharide (LPS) in mice. Here, we demonstrated that esculin suppressed inflammatory reactions in macrophages and protected mice from LPS-induced endotoxin shock. We found that esculin significantly inhibited the production of nitric oxide (NO) production via the inhibition of nuclear factor-κB (NF-κB) activation in macrophages. In animal model, esculin pretreatment significantly improved the survival rate of mice. LPS-induced increase of tumor necrosis factor alpha (TNF-α) and interleukin-6 (IL-6) in serum, lung, liver and kidney were markedly inhibited by esculin. IL-10, an anti-inflammatory cytokine, was up-regulated by esculin. Moreover, the histopathological analyses showed that esculin significantly attenuated the tissues injury of lung, liver, kidney in endotoxic mice. In addition, esculin significantly diminished the protein expression of NF-κB p65 in lung, liver, kidney, which resulted in lower levels of inflammatory mediators. These results suggest that esculin may be a potential drug for treatment of various inflammatory diseases.


Assuntos
Anti-Inflamatórios/farmacologia , Esculina/farmacologia , Lipopolissacarídeos/toxicidade , Óxido Nítrico/biossíntese , Choque Séptico/induzido quimicamente , Choque Séptico/tratamento farmacológico , Fator de Transcrição RelA/metabolismo , Animais , Anti-Inflamatórios/uso terapêutico , Esculina/uso terapêutico , Feminino , Regulação da Expressão Gênica/efeitos dos fármacos , Interleucina-10/sangue , Interleucina-6/biossíntese , Interleucina-6/sangue , Macrófagos/efeitos dos fármacos , Macrófagos/metabolismo , Masculino , Camundongos , Óxido Nítrico/sangue , Especificidade de Órgãos , Choque Séptico/metabolismo , Fator de Necrose Tumoral alfa/biossíntese , Fator de Necrose Tumoral alfa/sangue
10.
Int Immunopharmacol ; 38: 450-9, 2016 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-27380619

RESUMO

Cavidine, a major alkaloid compound isolated from Corydalis impatiens, has various pharmacological effects but its effect on gastric ulcer has not been previously explored. The current study aimed to investigate the possible anti-ulcerogenic potential of cavidine in the model of ethanol-induced gastric ulcer. Mice received cavidine (1, 5 or 10mg/kg, ig), cimetidine (CMD, 100mg/kg, ig) or vehicle at 12h and 1h before absolute ethanol administration (0.5mL/100g), and animals were euthanized 3h after ethanol ingestion. Gross and histological gastric lesions, biochemical, immunological and Western blot parameters were taken into consideration. The results showed that ethanol administration produced apparent mucosal injuries with morphological and histological damage, whereas cavidine pre-treatment reduced the gastric injuries. Cavidine pre-treatment also ameliorated the contents of malonaldehyde (MDA) and myeloperoxidase (MPO) activity, and increased the mucosa levels of glutathione (GSH), superoxide dismutase (SOD) and prostaglandin E2 (PGE2), relative to the model group. Also cavidine was able to decrease the levels of interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-α), inhibit the up-regulation of cyclo-oxygenase-2 (COX-2) expression and activation of Nuclear factor-kappa B (NF-κB) pathway. Taken together, these results indicated that cavidine exerts a gastroprotective effect against gastric ulceration, and the underlying mechanism might be associated with the stimulation of PGE2, reduction of oxidative stress, suppression of NF-κB expression and subsequent reduced COX-2 and pro-inflammatory cytokines.


Assuntos
Anti-Inflamatórios/uso terapêutico , Antioxidantes/uso terapêutico , Alcaloides de Berberina/uso terapêutico , Corydalis/imunologia , Mucosa Gástrica/efeitos dos fármacos , Úlcera Gástrica/tratamento farmacológico , Animais , Antioxidantes/administração & dosagem , Ciclo-Oxigenase 2/metabolismo , Dinoprostona/metabolismo , Etanol , Mucosa Gástrica/imunologia , Interleucina-6/metabolismo , Masculino , Camundongos , Camundongos Endogâmicos , NF-kappa B/metabolismo , Peroxidase/metabolismo , Úlcera Gástrica/induzido quimicamente , Superóxido Dismutase-1/metabolismo , Fator de Necrose Tumoral alfa/metabolismo
11.
Toxicol Appl Pharmacol ; 305: 46-54, 2016 08 15.
Artigo em Inglês | MEDLINE | ID: mdl-27260672

RESUMO

LPS sensitized mice are usually considered as an experimental model of endotoxin shock. The present study aims to evaluate effects of cavidine on LPS-induced endotoxin shock. Mice were intraperitoneally administrated with cavidine (1, 3 and 10mg/kg) or DEX (5mg/kg) at 1 and 12h before injecting LPS (30mg/kg) intraperitoneally. Blood samples, liver, lung and kidney tissues were harvested after LPS injection. The study demonstrated that pretreatment with cavidine reduced the mortality of mice during 72h after endotoxin injection. In addition, cavidine administration significantly attenuated histological pathophysiology features of LPS-induced injury in lung, liver and kidney. Furthermore, cavidine administration inhibited endotoxin-induced production of pro-inflammatory cytokines including TNF-α, IL-6 and HMGB1. Moreover, cavidine pretreatment attenuated the phosphorylation of mitogen-activated protein kinase primed by LPS. In summary, cavidine protects mice against LPS-induced endotoxic shock via inhibiting early pro-inflammatory cytokine TNF-α, IL-6 and late-phase cytokine HMGB1, and the modulation of HMGB1 may be related with MAPK signal pathway.


Assuntos
Alcaloides de Berberina/farmacologia , Alcaloides de Berberina/uso terapêutico , Substâncias Protetoras/farmacologia , Substâncias Protetoras/uso terapêutico , Choque Séptico/tratamento farmacológico , Animais , Células Cultivadas , Feminino , Proteína HMGB1/antagonistas & inibidores , Interleucina-6/antagonistas & inibidores , Rim/efeitos dos fármacos , Rim/metabolismo , Rim/patologia , Lipopolissacarídeos , Fígado/efeitos dos fármacos , Fígado/metabolismo , Fígado/patologia , Pulmão/efeitos dos fármacos , Pulmão/metabolismo , Pulmão/patologia , Macrófagos Peritoneais/efeitos dos fármacos , Macrófagos Peritoneais/metabolismo , Masculino , Camundongos , Proteínas Quinases Ativadas por Mitógeno/metabolismo , Choque Séptico/induzido quimicamente , Choque Séptico/metabolismo , Choque Séptico/patologia , Fator de Necrose Tumoral alfa/antagonistas & inibidores
12.
Inflammation ; 39(2): 786-97, 2016 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-26846885

RESUMO

Nobiletin (NOB), the major bioactive component of polymethoxyflavones in citrus fruits, has been reported possessing significant biological properties. The purpose of the present study was to investigate the protective role of NOB on lipopolysaccharide (LPS)-induced endotoxic shock in mice. We found pretreatment with NOB increases the survival rate of mice after endotoxin injection. The present study clearly demonstrates that pretreatment with NOB decreases the production of early pro-inflammatory cytokines TNF-α, IL-6, and late-phase mediator HMGB1 in serum and tissues of kidney, lung, and liver. The histopathological study indicates that NOB administration significantly attenuate tissues injury induced by LPS. Moreover, NOB suppresses the activity of nuclear factor-kappa B (NF-κB). These results suggest that NOB protects mice against LPS-induced endotoxic shock through inhibiting the production of TNF-α, IL-6, and HMGB1 and the activation of NF-κB, which elucidate that NOB may be a promising drug candidate for the treatment of septic shock.


Assuntos
Flavonas/uso terapêutico , Proteína HMGB1/antagonistas & inibidores , Interleucina-6/antagonistas & inibidores , NF-kappa B/metabolismo , Choque Séptico/prevenção & controle , Fator de Necrose Tumoral alfa/antagonistas & inibidores , Animais , Flavonas/efeitos adversos , Proteína HMGB1/sangue , Interleucina-6/sangue , Rim/patologia , Lipopolissacarídeos/toxicidade , Fígado/patologia , Pulmão/patologia , Macrófagos/imunologia , Masculino , Camundongos , Choque Séptico/tratamento farmacológico , Fator de Necrose Tumoral alfa/sangue
13.
Int Immunopharmacol ; 29(2): 779-786, 2015 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-26391063

RESUMO

Esculin, a coumarinic derivative found in Aesculus hippocastanum L. (Horse-chestnut), has been reported to have potent anti-inflammatory properties. The present study is designed to investigate the protective effects of esculin on various inflammation models in vivo and in vitro and to clarify the possible mechanism. Induced-animal models of inflammation and lipopolysaccharide (LPS)-challenged mouse peritoneal macrophages were used to examine the anti-inflammatory activity of esculin. In present study, xylene-induced mouse ear edema, carrageenan-induced rat paw edema, and carrageenan-induced mouse pleurisy were attenuated by esculin. In vitro, the pro-inflammatory cytokine levels of tumor necrosis factor-α (TNF-α) and interleukin-6 (IL-6) in supernatant were reduced by esculin. Meanwhile, we found that esculin significantly inhibited LPS-induced activation of mitogen-activated protein kinase (MAPK) pathway in peritoneal macrophages. These results suggest that esculin has potent anti-inflammatory activities in vivo and in vitro, which may involve the inhibition of the MAPK pathway. Esculin may be a promising preventive agent for inflammatory diseases in human.


Assuntos
Anti-Inflamatórios não Esteroides/farmacologia , Esculina/farmacologia , Interleucina-6/biossíntese , Lipopolissacarídeos/farmacologia , Macrófagos Peritoneais/efeitos dos fármacos , Proteínas Quinases Ativadas por Mitógeno/efeitos dos fármacos , Fator de Necrose Tumoral alfa/biossíntese , Animais , Carragenina , Edema/induzido quimicamente , Edema/prevenção & controle , Ativação Enzimática/efeitos dos fármacos , Feminino , Masculino , Camundongos , Pleurisia/induzido quimicamente , Pleurisia/prevenção & controle , Ratos , Transdução de Sinais/efeitos dos fármacos , Xilenos
14.
Chem Biol Interact ; 239: 34-45, 2015 Sep 05.
Artigo em Inglês | MEDLINE | ID: mdl-26102009

RESUMO

Ulcerative colitis is an inflammatory disorder characterized by neutrophils infiltration, oxidative stress, upregulation of pro-inflammatory mediators and cytokines. Cavidine possesses anti-inflammatory activity and has been used to treat various inflammatory diseases but its effect on ulcerative colitis has not been previously explored. The present study aims to evaluate the effect of cavidine on acetic acid-induced ulcerative colitis in mice. Colitis mice induced by intra-rectal acetic acid (5%, v/v) administration received cavidine (1, 5 and 10mg/kg, i.g) or sulfasalazine (500mg/kg, i.g) for seven consecutive days. After euthanized by cervical dislocation, colonic segments of mice were excised for clinical, macroscopic, biochemical and histopathological examinations. Results suggested treatment with cavidine significantly decreased mortality rate, body weight loss, disease activity index (DAI), wet colon weight, macroscopic and histological score when compared with that of acetic acid-induced controls. In addition, administration of cavidine effectively modulated expressions of MPO, GSH, SOD and MDA. Furthermore cavidine inhibited the level of TNF-α and IL-6 in the serum and colon tissue in response to the regulation of p65 NF-κB protein expression. All these results indicated cavidine exerts marked protective effect in experimental colitis, possibly by regulating the expression of oxygen metabolites, NF-κB and subsequent pro-inflammatory cytokines production.


Assuntos
Antiulcerosos/farmacologia , Alcaloides de Berberina/farmacologia , Colite Ulcerativa/tratamento farmacológico , Colite Ulcerativa/metabolismo , Ácido Acético , Animais , Antioxidantes/metabolismo , Colite Ulcerativa/induzido quimicamente , Colo/efeitos dos fármacos , Colo/metabolismo , Colo/patologia , Citocinas/metabolismo , Modelos Animais de Doenças , Glutationa/metabolismo , Interleucina-6/sangue , Masculino , Camundongos , NF-kappa B/metabolismo , Peroxidase/metabolismo , Transdução de Sinais/efeitos dos fármacos , Fator de Necrose Tumoral alfa/sangue , Fator de Necrose Tumoral alfa/metabolismo
15.
Shanghai Kou Qiang Yi Xue ; 24(1): 118-20, 2015 Feb.
Artigo em Chinês | MEDLINE | ID: mdl-25858383

RESUMO

PURPOSE: To observe the effect of removable denture with metal stent of baked plastic occlusal pad in the reconstruction of dentition defects accompanied with severe residual teeth attrition. METHODS: Twenty one patients were selected with dentition defects accompanied with severe residual teeth attrition, who needed occlusal reconstruction. Their removable dentures with metal stent of baked plastic occlusal pad were reconstructed, and their occlusal vertical dimensions were restored. The restoration effect was evaluated. RESULTS: Twenty-one patients were treated and followed up for 12-24 months. Excellent results were achieved in 18 patients, and fair results were obtained in 3 patients. CONCLUSIONS: Using the baked plastic occlusal pad can not only recover patients' occlusal vertical dimension, but also restore the shapes and function of their residual teeth to a better extent. It is a good method for occlusal reconstruction.


Assuntos
Placas Oclusais , Plásticos , Dimensão Vertical , Humanos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...